Navitas Life Sciences’ innovative Regulatory Technology, pharmaREADY®, achieves 200 active customers
Wednesday, 08 September 2021

Navitas Life Sciences, a TAKE Solutions company, announces that it has achieved its 200th customer win for its innovative Regulatory Technology,

Continue Reading
Navitas Life Sciences has been named as a Major Contender in Everest Group’s Pharmacovigilance and Complaint Management Operations - Services PEAK Matrix Assessment 2021
Thursday, 15 April 2021

Navitas Life Sciences, a wholly owned subsidiary of TAKE Solutions and provider of Pharmacovigilance, Regulatory, and Clinical solutions and services today announced

Continue Reading
Navitas Life Sciences Provides Improved Clinical Trial Oversight and Actionable Insights Enabled by OneClinical™ Analytics, Powered by ThoughtSphere
Monday, 24 June 2019

ThoughtSphere, a fast growing, cloud-based clinical data hub and analytics SaaS company, today announced that Navitas Life Sciences, a full service CRO....

Continue Reading
Navitas Life Sciences announces acquisition of KAI Research, US-based full-service Contract Research Organisation (CRO)
Tuesday, 21 May 2019

Navitas Life Sciences, a TAKE Solutions Enterprise today announced the acquisition of US based niche full service CRO and health research company, KAI Research Inc...

Continue Reading
Navitas Life Sciences announces acquisition of DataCeutics Inc to augment global Clinical Data Science Services
Wednesday, 13 February 2019

Navitas Life Sciences, a TAKE Solutions Enterprise today announced that it will be acquiring Life Sciences services player, DataCeutics in North America.

Continue Reading
Navitas Life Sciences strengthens leadership team
Thursday, 10 January 2019

Navitas Life Sciences, a TAKE Solutions Enterprise announced the appointment of Dr. Steve Galen as the Global Head of Clinical...

Continue Reading
Navitas Life Sciences, a TAKE Solutions Enterprise, has been named as a Leader in IDC MarketScape: Worldwide Life Science R&D BPO Services 2018 Vendor Assessment
Thursday, 12 July 2018

Navitas Life Sciences, a wholly owned subsidiary of TAKE Solutions and a full service Clinical, Regulatory & Safety solutions and services provider today announced that it has been recognized as a ‘Leader’...

Continue Reading
Over 300 members attend the June New York and London Nets Forum Meetings
Wednesday, 27 June 2018

Throughout June, Navitas Life Sciences hosted a series of forum meetings in London and New York across our expanding portfolio of industry leading networks...

Continue Reading
Navitas Life Sciences at the 11th Indian Society for Clinical Research (ISCR) annual conference, Bangalore
Wednesday, 24 January 2018

Navitas Life Sciences, as a Gold Sponsor, participated at the 11th Annual conference themed “Collaborative Clinical Research for better Patient outcomes”,...

Continue Reading
Navitas brings End – to – End R&D Solutions to the Generic Drug Industry
Friday, 01 December 2017

Navitas Life Sciences, a TAKE Solutions Enterprise, provides services and technology to deliver “first to file” results to generic drug companies around the globe,...

Continue Reading
Page 1 of 5